Literature DB >> 8314304

Induction of tissue-type plasminogen activator and 72-kDa type-IV collagenase by ionizing radiation in rat astrocytes.

R Sawaya1, P J Tofilon, S Mohanam, F Ali-Osman, L A Liotta, W G Stetler-Stevenson, J S Rao.   

Abstract

Radiation-induced damage in the central nervous system (CNS) is believed to be targeted to glial or endothelial cells or both, although the pathophysiology of the process is still poorly understood. In this study, we irradiated rat astrocytes with single doses of X-rays and then estimated the levels of tissue plasminogen activator (tPA) and collagenase in serum-free medium and cell extracts at different times. Fibrin zymography revealed increased levels of intracellular tPA activity at 12 hr after irradiation. Gelatin zymography showed continuously increasing levels of extracellular 72-kDa type-IV collagenase after irradiation. Quantitative enzymatic activities by densitometry showed a 3- to 4-fold elevation in the level of the intracellular tPA activity at 12 hr and a 5- to 6-fold increase in the level of the extracellular 72-kDa type-IV collagenase activity at 48 hr. An ELISA with specific antibodies for tPA and 72-kDa type-IV collagenase indicated a 5-fold increase in the level of tPA at 12 hr and a more-than-7-fold increase in the level of 72-kDa type-IV collagenase at 48 hr. This study adds considerable credibility to the proposed role of plasminogen activators and type-IV collagenase in the development of CNS damage after radiotherapy for brain tumors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8314304     DOI: 10.1002/ijc.2910560212

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

Review 1.  Extracellular matrix degradation by metalloproteinases and central nervous system diseases.

Authors:  A Lukes; S Mun-Bryce; M Lukes; G A Rosenberg
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

Review 2.  The potential influence of radiation-induced microenvironments in neoplastic progression.

Authors:  M H Barcellos-Hoff
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

3.  Modulation of fibrinolysis by ionizing radiation.

Authors:  J S Rao; A Rayford; M Yamamoto; K K Ang; P Tofilon; R Sawaya
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 4.  Latency and activation in the control of TGF-beta.

Authors:  M H Barcellos-Hoff
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-10       Impact factor: 2.673

5.  Radiation-induced blood-brain barrier damage in astrocytoma: relation to elevated gelatinase B and urokinase.

Authors:  J C Adair; N Baldwin; M Kornfeld; G A Rosenberg
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

6.  Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions.

Authors:  Z Li; L Li; H R Zielke; L Cheng; R Xiao; M T Crow; W G Stetler-Stevenson; J Froehlich; E G Lakatta
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

7.  Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells.

Authors:  Chandramu Chetty; Praveen Bhoopathi; Jasti S Rao; Sajani S Lakka
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

Review 8.  Whole brain radiation-induced cognitive impairment: pathophysiological mechanisms and therapeutic targets.

Authors:  Yong Woo Lee; Hyung Joon Cho; Won Hee Lee; William E Sonntag
Journal:  Biomol Ther (Seoul)       Date:  2012-07       Impact factor: 4.634

9.  MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells.

Authors:  Aruna Venkata Badiga; Chandramu Chetty; Divya Kesanakurti; Deepthi Are; Meena Gujrati; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

10.  Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer.

Authors:  A Kumar; H M Collins; J H Scholefield; S A Watson
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.